Google
NPCE — NEUROPACE INC (Healthcare >> Medical Devices)
NPCE FAQ
What is NPCE's ROE?
NEUROPACE INC reports a Return on Equity (ROE) of -149.20%.
What is NPCE's dividend yield?
NEUROPACE INC offers a dividend yield of 0.00%.
What is NPCE's Deepscope Quality Score?
Deepscope rates NPCE's overall financial quality at 38 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy NPCE?
Deepscope's AI Timing Score for NPCE is 70 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does NPCE belong to?
NEUROPACE INC is classified under the Healthcare >> Medical Devices sector on the NASDAQ exchange.
|
USD 16.32
Price
0.44
(2.77%)
Day Change
|
|
|---|
NPCE, ファンダメンタルスコアはnot good ( ファンダメンタル = 38) but テクニカルスコアは ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROEが低い
ROAが低い
平均ROEが低い
ROEが昨年度比で低い
ROAの伸びが低い
NPMが低い
NPMの伸びが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not good , and ability to make profit is not quite good , ...
| Deepscope 分析 |
|
42% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 99 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 16.32 |
| PBV / Sector |
38.42 / 7.50
|
| Earning Per Share | -0.63 |
| PE / Sector |
N/A / 28.68
|
| PEG or PE/Growth / Sector |
N/A / 0.39
|
| Average 1M Daily Value |
3.51 M
GREAT
|
| Average 1W Daily Value |
2.96 M
GREAT
|
| Timing Factors |
|
28% |
| Financial Health |
|
37% |
| ポイントになる統計 |
|
56% |
| 配当 |
|
4% |
| 登録情報 |
| Analyze Date | 2026-06-05 09:11:54 |
| Symbol | NPCE |
| Name | NEUROPACE INC |
| Sector | Healthcare >> Medical Devices |
| Market | NASDAQ |
| Listed Shares | 34.09 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 555.39 / 18,060.39 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 455 North Bernardo Avenue, Mountain View, CA, United States, 94043
Phone: 650 237 2700
Website: https://www.neuropace.com
Employees: 220
Sector: Healthcare >> Medical Devices
Description: NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. In addition, the company provides physician tablet which is used for prescribing and managing clinicians for programming implanted devices and managing patient care; and patient data management system, a secure online database that collects data that have been recorded by the RNS System; and nSight Platform, which provide clinicians with personalized patient reports, as well as programming suggestions. It sells its products to hospital facilities for initial RNS System implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.
ME vs SECTOR Healthcare >> Medical Devices
Click a bubble to view stock details · Bubble size represents market capitalization share
